Filing summary
IceCure Medical Ltd. furnished this Form 6-K for September 2026, signed September 28, 2026. The filing announces an annual and special shareholder meeting scheduled for November 2, 2026. Shareholders of record at the close of business on October 5, 2026 are entitled to notice and to vote.
Financial information
This filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics, and contains no guidance or financial outlook.
Material information and potential significance
The filing furnishes the meeting notice, proxy statement, and proxy card as Exhibits 99.1, 99.2, and 99.3. It does not include their contents in the text provided, so the meeting proposals and related details are not clear from this filing text. The 6-K is incorporated by reference into the company’s specified Form F-3 and Form S-8 registration statements, to the extent not superseded by later filings.
Investor verification points
- Review the proxy statement and proxy card for the proposals, voting requirements, and any compensation or governance matters.
- Confirm the October 5, 2026 record date and November 2, 2026 meeting date, including any updates or adjournments.
- Assess whether any matters in the proxy materials could affect shareholders or the company’s securities.